Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype

NCT02135263 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Carboxylesterase 1 (CES1) Genotype
CES1 Activity

Interventions

DRUG: Methylphenidate
DRUG: Enalapril

Sponsor

Bispebjerg Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]